ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 123 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,800,000 | -38.5% | 182,686 | -3.2% | 0.00% | -50.0% |
| Q3 2016 | $6,183,000 | +32.4% | 188,670 | +0.9% | 0.01% | +33.3% |
| Q2 2016 | $4,671,000 | +104.9% | 187,060 | +101.0% | 0.01% | +100.0% |
| Q1 2016 | $2,280,000 | -37.2% | 93,080 | -15.2% | 0.00% | -40.0% |
| Q4 2015 | $3,628,000 | +1.8% | 109,825 | +0.9% | 0.01% | 0.0% |
| Q3 2015 | $3,565,000 | -37.3% | 108,817 | +1.4% | 0.01% | -28.6% |
| Q2 2015 | $5,684,000 | +203.6% | 107,298 | +65.4% | 0.01% | +250.0% |
| Q1 2015 | $1,872,000 | +60.1% | 64,857 | +61.4% | 0.00% | 0.0% |
| Q4 2014 | $1,169,000 | +132.4% | 40,180 | +1.2% | 0.00% | +100.0% |
| Q3 2014 | $503,000 | -36.6% | 39,700 | +0.3% | 0.00% | 0.0% |
| Q2 2014 | $794,000 | – | 39,585 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |